New lupus drug enters human testing phase
NCT ID NCT07215663
Summary
This early-stage study is testing a new drug called cizutamig in people with systemic lupus erythematosus (lupus). The main goal is to check if the drug is safe and how the body handles it, in 47 adults with active lupus. Researchers will monitor side effects and how the drug moves through the body to decide if larger studies are warranted.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese Academy of Medical Sciences and Peking Union Medical College Hospital
RECRUITINGBeijing, China
Conditions
Explore the condition pages connected to this study.